correlation and timing of *appearance* says it all
and
correlation and timing of *appearance* says it all
and it's not unique to this SMB
the whining can be read by all with interest
and has been duly noted
flat out falsehood posts get deleted here
there is a site that welcomes them .. it isn't this one
lastly the negative focus on PTOI's historical documentation
as being an issue gives every indication
of trolling .. look it up .. as noted recently .. i liked it better
when .. had me on ignore .. vs the pretense of it
disputing factual data for the sake of *posting* is trolling
and it is always telling to me (and some others) as to why
NR and trading crews .. have always targeted factual historical data
but never more so until February 2010 .. when the DRS % link (implemented
at the behest of the SEC) via Finra first went live
for months *there* (2010) .. this very subject was verboten and posts
showing the DRS % on specific *OTC targets* were removed as OT
realize few OTC targets .. survive let alone outlast NRs' *efforts*
so NR and trading crews needed *new* talking points .. because for years these
entities' posted that there was no such thing as shorting OTC stocks
coincidentally the author of PTOI's first hit piece spread this bogus bs at every turn
of course back then (due to P2O's actual investors vs those who trade and were loosely affiliated with the *original* trading crew embedded in P2O since 2009) the usual by rote working of a stock was to cycle up .. cycle back .. cycle up .. cycle back
with P2O's founder having actual investors (to this day many of whom have never sold one share) .. the by rote conditioning of certain *original* NR trading crews' posting on P2O's SMB .. had little effect .. which is why NR was so significantly upside down from the *hand off* of December 2009 into January 2010
by the EO December 2010 .. NR was significantly *stuck* (Upside Down) it's why in July of 2010 .. 2 separate *efforts* were undertaken by NR .. but the clutch move of September 2010 by NR was the set up for what would come to pass in 2011
in the meantime the founder of P2O .. would scale tech from table top to flagship in 4 years (2009 - 2013)
the easiest aspect NR controls on an OTC target is the PPS .. since 12/31/13 and 10/9/14 .. PTOI (the stock) has been held at or mostly below 10c and 5c respectively
again to point out what most can understand .. when investors actually sell .. volume increases .. it doesn't decrease
since P2O (the company) was wrested back in mid August 2013 .. PTOI's volume
has decreased YOY YTD .. with one exception .. 2018 .. PTOI had 13M and change go off .. slightly more (about 500,000 shares) than 2017's 13M and change
NR is beyond *stuck* on PTOI (the stock) .. NRs' MO is to always brutalize an UPSIDE DOWN OTC TARGET .. because it will always impact mgmt's ability to execute
over the coming days .. P2O will either file their annual (expense expended) or an NT indicating the intent by the company
or they won't
all the whining in the world on this board .. will not change what P2O's CEO & BoD
have scheduled
and no one here knows what is en route ..
the only aspect every *actual* P2O investor determines is whether they buy/sell or hold their PTOI *shares* .. (since it's clear by the always decreasing volume in play and what has had to be *marked* recently) it's equally clear that whomever tapped the *hidden* and non hidden volume of 1.29.19 .. it wasn't retail
so pointing out that PTOI's volume *imo* is being wash traded for volume maintenance
gets maligned consistently by *entities* .. most of whom are part of the original crew (both sides .. pro/con .. well covered .. there) embedded in P2O
so why exactly would that be .. it is crystal clear based on *volume* .. there are little to none news on P2O
and imo that will remain until the CEO & BoD .. actually give a reason for new eyes to enter .. which is as it should be
so it's not for new eyes ..
so ask yourself why the *crew* would have such an issue with historical/factual data re: PTOI?
it isn't rocket science .. but it is math
4kids
Plastic2Oil, Inc. (PTOI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...
Continue Reading
Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...
Continue Reading
Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...
Continue Reading
Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...
Continue Reading
Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...
Continue Reading
Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...
Continue Reading
A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...
Continue Reading
Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...
Continue Reading
Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...
Continue Reading
If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...
Continue Reading
Top 5 Most Recently Viewed Articles
Volvo's Shift Away from LiDAR Technology Recently, the Swedish automaker Volvo announced its decision to cease its partnership with Luminar Technologies Inc. (NASDAQ: LAZR). This bold move has caught the attention of the automotive industry, especially those tracking advancements in autonomous vehicle technology. By not integrating LiDAR technology into its forthcoming...
Continue Reading
Samsung and Xiaomi Face Antitrust Investigation in India Samsung, Xiaomi, and various other smartphone manufacturers are under serious scrutiny for allegedly colluding with major e-commerce platforms in India, undermining fair market practices. The Competition Commission of India (CCI) has gathered evidence that suggests these companies coordinated with Amazon and...
Continue Reading
Bonnie Navin Attributes and Accolades Bonnie Navin of Rubenstein Law has recently earned a significant honor by being selected as a member of the Medical Malpractice Trial Lawyers Association - Top 25. This elite recognition is awarded to the most distinguished attorneys specializing in medical malpractice across the nation, and it showcases Navin's exceptional skill and...
Continue Reading
Success in the business world has never been a cakewalk. Many new ventures stumble within a decade, and only a handful manage to stay afloat while also boasting a robust and growing dividend program. Companies that consistently dish out dividends reflect financial health, but there’s more to the story. Take Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE:...
Continue Reading
Cathie Wood's Deflationary Boom Forecast Amid Market Turbulence CEO of Ark Funds, Cathie Wood, has made bold predictions regarding a potential "deflationary boom" despite significant losses in the stock market. Recent trading sessions saw renowned tech stocks, collectively known as the Magnificent Seven, lose about $780 billion in market capitalization in a single day,...
Continue Reading